(833) 317-6278
Book a Demo
Zachary Brennan
Gray shield icon
Is this you?
Claim your profile.

Zachary Brennan

Senior Editor

AS SEEN ON
Endpoints News

Preston's Summary

Zachary Brennan is a Senior Editor at Cureus Journal of Medical Science and Endpoints News. He specializes in medicine and healthcare, focusing on topics such as FDA regulations, alternative medicine, and healthcare technology, while also covering significant issues like the Coronavirus pandemic and inflation in the healthcare sector. Zachary's insights and analyses have been featured in prominent publications, including Cureus Journal of Medical Science and Endpoints News.

Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston

Geo Focus

United States (National)

Coverage Attributes:

Beta
Government Announcement: 39 %
Legal Policy Regulation: 25 %
Press Release: 23 %
Cites Data: 2 %
Industry Specific: 1 %

Themes Covered:

Not enough data icon

Not enough data

Most Recent Topics:

  • Health News
  • Healthcare Administration
  • Gene Therapy

Pitching Insights

Zachary Brennan's coverage overwhelmingly focuses on healthcare and pharmaceuticals, particularly around government announcements and legal policy regulations. He seems most interested in covering stories related to the FDA, drug approval processes, drug pricing, pharmaceutical companies, and clinical trials.

Given this focus, Zachary would likely be highly receptive to pitches from experts within the healthcare industry who can provide insights into regulatory changes impacting drug approvals or pricing. Additionally, professionals with expertise in clinical trials oversight or experience navigating FDA processes may find success reaching out to him for commentary.

As his geographic focus is not specified but given the nature of his reporting which heavily involves U.S. government agencies such as the FDA and specific U.S.-related policies like drug price regulation laws; it is fair to assume he has a U.S.-centric perspective.

This information evolves through artificial intelligence and human feedback. Improve this profile .

Journalists With Similar Coverage:

Based on similarity of content.
Max Bayer

Max Bayer

Pharma Reporter
*****m@*********om
Publications
Endpoints News
Most recent topics
Not enough data
Nicole Defeudis

Nicole Defeudis

Editor
*****e@********om
Publications
Endpoints News
Most recent topics
Not enough data
Lia Degroot

Lia Degroot

Healthcare Policy Reporter
*********ot@***********com
Publications
CQ and Roll Call, Lawton Publishing Company, rv-times.com, SAMMY A. CAVES, D.M.D., P.C., The Seattle Times
Most recent topics
Not enough data
Ayisha Sharma

Ayisha Sharma

Biopharma Breaking News Reporter
******a@********om
Publications
Endpoints News
Most recent topics
Not enough data
Mari Serebrov

Mari Serebrov

Biopharma writer; Author
**********rov@**********com
Publications
Bioworld co.
Most recent topics
Not enough data
Urtė Fultinavičiūtė

Urtė Fultinavičiūtė

Publications
Clinical Trials Arena
Most recent topics
Not enough data

Articles

© 2025 Intelligent Relations